Insurance giant Metlife has launched legal proceedings against the Australian Financial Complaints Authority to challenge a finding in favour of an injured former NSW police officer, in what is the first Federal Court action against the new external dispute resolution body.
The High Court has upheld an appeal by a mortgage broker with a history of run-ins with the law, finding that the Administrative Appeals Tribunal could not take spent convictions into account when reviewing ASIC ban orders.
A judge has granted a bid to add former Radio Rentals CEO James Marshall and the beleaguered company’s insurer, AIG Australia, as respondents in a class action, over the protests of Marshall’s lawyer, who said his client couldn’t afford to pay for his defence.
A judge has dismissed HWL Ebsworthâs claims of a âfishing expeditionâ and granted discovery of a slew of internal documents relevant to allegations a partner at the law firm encouraged a companyâs directors to unlawfully divert insurance proceeds to pay almost $150,000 in legal bills.
Insurance Australia Limited is facing a class action alleging it engaged in misleading and deceptive conduct by pushing worthless add-on insurance onto individuals purchasing motor vehicles through authorised dealers.
AFT Pharmaceuticals has accused rival Reckitt Benckiser of using the court as a “clearance house” to beat its competitors, the latest development in a long-running dispute over AFT’s Maxigesic ads.
Trial in a shareholder class action against engineering company WorleyParsons will be heard by a new judge in late August, six months after it was unexpectedly vacated.
AFT Pharmaceuticals has agreed to a court order temporarily restraining it from distributing point of sale material containing updated claims that its painkiller Maxigesic is more effective than other over-the-counter medications.
AFT Pharmaceuticals has launched a partial challenge to a court ruling that its Maxigesic ads made a number of misleading claims, including that the drug provides stronger and more effective relief than Reckitt Benckiser’s Nuromol.
The Australian Securities and Investments Commission will likely appeal a ruling that two Westpac units did not provide personal financial advice as part of a campaign encouraging customers to roll over external superannuation accounts.